Lack of antibiotics impairs patient care, raises treatment expenses, decreases efficacy, and fuels the global spread of antibiotic resistance.
In an opinion piece published in Humanities and Social Sciences Communications, researchers from the University of Oslo have emphasized how antibiotic shortages have progressed from regional and isolated problems to a worldwide emergency. They now call for a worldwide review of the efficacy of regulations and the resilience of supply chains.
"Strategies to specifically address antibiotic shortages remain underexplored," contends Belma Skender, a postdoctoral fellow.
An outline of the problem's history from the 1970s to the present is given in their article. They demonstrate how pharmaceutical research, manufacturing, value, and production locations have been influenced by market forces and financial considerations.
According to the experts, there are several reasons behind the recent antibiotic shortages in wealthy nations. These include the pharmaceutical industry's economic, logistical, and regulatory aspects, which have changed significantly and methodically during the last few decades.
CMI Research: Key Antibiotics Market Insights
The growing need for efficient antibiotics to treat bacterial infections is predicted to propel the antibiotics market's 5.1% compound annual growth rate (CAGR) between 2024 and 2031, according to Coherent Market Insights (CMI). By 2031, the antibiotics market is expected to have grown from its 2024 valuation of roughly US$55.33 billion to US$78.24 billion.
With the largest market share, North America is expected to grow over the forecast period. The causes of industry dominance include rising infectious disease cases, high incidence of administering non-prescribed medications, the presence of well-established clinics & hospitals, and a growing number of skilled professionals in the region.
Analyst Opinion: Strategic Role in Antibiotics Market Growth
Senior management consultant Vipul Patil claims that the growing antimicrobial resistance globally presents potential prospects for the global antibiotics market. One important factor is the rise in antibiotic resistance, which is driving more research and development for novel medication classes. Markets are constrained by strict drug approval requirements.
Conclusion: Business Takeaways
The antibiotics market offers substantial economic potential due to the increasing demand for efficient infection treatments worldwide. The growing significance of antimicrobial resistance, which increases the demand for novel antibiotic breakthroughs, is one of the main lessons learned.
Businesses that concentrate on research and development will prosper, especially in the areas of new antibiotics and substitutes. Long approval processes and regulatory barriers still exist, but market access can be sped up through smart alliances and partnerships with biotech companies.
